Prajeeth CK, Zdora I, Saletti G, Friese J, Gerlach T, Wilken L, Beicht J, Kubinski M, Puff C, Baumgärtner W, Kortekaas J, Wichgers Schreur PJ, Osterhaus ADME, Rimmelzwaan GF (2024). Immune correlates of protection of the four-segmented Rift Valley fever virus candidate vaccine in mice. Emerg Microbes Infect. 13/2024;
PubMed
Kiemel D, Kroell AH, Denolly S, Haselmann U, Bonfanti JF, Andres JI, Ghosh B, Geluykens P, Kaptein SJF, Wilken L, Scaturro P, Neyts J, Van Loock M, Goethals O, Bartenschlager R (2024). Pan-serotype dengue virus inhibitor JNJ-A07 targets NS4A-2K-NS4B interaction with NS2B/NS3 and blocks replication organelle formation. Nat Commun. 15/2024;
PubMed
Wilken L, Lasswitz L, Scaturro P, Gerold G (2024). Identification of RVFV Host Factors Using Quantitative Interaction Proteomics. Methods Mol Biol. 2824/2024;
PubMed
